Zobrazeno 1 - 10
of 27
pro vyhledávání: '"Koornstra RH"'
Autor:
van Zeijl, MCT, Van den Eertwegh, AJM, Wouters, MWJM, Jochems, A, Schouwenburg, MG, Haanen, JBAG, Aarts, MJ, van den Berkmortel, FWPJ, de Groot, JWB, Hospers, GAP, Kapiteijn, E, Koornstra, RH, Piersma, D, van Rijn, RS, Suijkerbuijk, KPM, ten Tije, AJ, van der Veldt, Astrid, Vreugdenhil, G, van der Hoeven, KJM
Publikováno v:
Nederlands Tijdschrift voor Geneeskunde, 162:D2420. Bohn Stafleu van Loghum
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=narcis______::c0f75d05a21b410ea44f763521d221b2
https://pure.eur.nl/en/publications/7d05ac42-34e9-414d-85cc-276ea6280c0f
https://pure.eur.nl/en/publications/7d05ac42-34e9-414d-85cc-276ea6280c0f
Autor:
Jochems A; Department of Medical Oncology, Leiden University Medical Centre, Albinusdreef 2, po box 9600, 2300 RC Leiden, The Netherlands. a.jochems@lumc.nl.; Dutch Institute for Clinical Auditing, Rijnsburgerweg 10, 2333 AA Leiden, The Netherlands. a.jochems@lumc.nl., van der Kooij MK; Department of Medical Oncology, Leiden University Medical Centre, Albinusdreef 2, po box 9600, 2300 RC Leiden, The Netherlands., Fiocco M; Medical Statistics, Department of Biomedical Data Sciences, Leiden University Medical Centre, Albinusdreef 2, po box 9600, 2300 RC Leiden, The Netherlands.; Mathematical Institute Leiden University, Niels Bohrweg 1, 2333 CA Leiden, The Netherlands., Schouwenburg MG; Department of Medical Oncology, Leiden University Medical Centre, Albinusdreef 2, po box 9600, 2300 RC Leiden, The Netherlands.; Dutch Institute for Clinical Auditing, Rijnsburgerweg 10, 2333 AA Leiden, The Netherlands., Aarts MJ; Department of Medical Oncology, Maastricht University Medical Centre, P. Debyelaan 25, 6202 AZ Maastricht, The Netherlands., van Akkooi AC; Department of Surgical Oncology, Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Plesmanlaan 121, 1066 CX Amsterdam, The Netherlands., van den Berkmortel FWPJ; Department of Medical Oncology, Zuyderland Medical Centre, 6130 MB Sittard-Geleen, The Netherlands., Blank CU; Department of Medical Oncology, Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Plesmanlaan 121, 1066 CX Amsterdam, The Netherlands., van den Eertwegh AJM; Department of Medical Oncology, VU Medical Centre, de Boelelaan 1117, 1081 HZ Amsterdam, The Netherlands., Franken MG; Department of Health Technology Assessment, Institute for Medical Technology Assessment and Erasmus School of Health Policy & Management, Erasmus University, Burgemeester Oudlaan 50, 3000 DR Rotterdam, The Netherlands., de Groot JB; Department of Medical Oncology, Isala Oncological Center, 8000 GK Zwolle, The Netherlands., Haanen JBAG; Department of Medical Oncology, Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Plesmanlaan 121, 1066 CX Amsterdam, The Netherlands., Hospers GAP; Department of Medical Oncology, University Medical Centre Groningen, Hanzeplein 1, 9713 GZ Groningen, The Netherlands., Koornstra RH; Department of Medical Oncology, Radboud University Medical Centre, Geert Grooteplein Zuid 10, 6500 HB Nijmegen, The Netherlands., Kruit WHJ; Department of Medical Oncology, Erasmus MC Cancer Institute, Molewaterplein 40, 3000 CA Rotterdam, The Netherlands., Louwman M; Netherlands Comprehensive Cancer Organisation, PO Box 19079, 3501 DB Utrecht, The Netherlands., Piersma D; Department of Medical Oncology, Medisch Spectrum Twente, Koningsplein 1, 7512 KZ Enschede, The Netherlands., van Rijn RS; Department of Medical Oncology, Medical Centre Leeuwarden, Henri Dunantweg 2, 8934 AD Leeuwarden, The Netherlands., Suijkerbuijk KPM; Department of Medical Oncology, University Medical Centre Utrecht, Heidelberglaan 100, 3584 CX Utrecht, The Netherlands., Ten Tije AJ; Department of Medical Oncology, Amphia Ziekenhuis, Langendijk 175, 4819 EV Breda, The Netherlands., Vreugdenhil G; Department of Medical Oncology, Maxima Medisch Centrum, de Run 4600, 5500 MB Veldhoven, The Netherlands., Wouters MWJM; Dutch Institute for Clinical Auditing, Rijnsburgerweg 10, 2333 AA Leiden, The Netherlands.; Department of Surgical Oncology, Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Plesmanlaan 121, 1066 CX Amsterdam, The Netherlands., van Zeijl MCT; Department of Medical Oncology, Leiden University Medical Centre, Albinusdreef 2, po box 9600, 2300 RC Leiden, The Netherlands.; Dutch Institute for Clinical Auditing, Rijnsburgerweg 10, 2333 AA Leiden, The Netherlands., van der Hoeven KJM; Department of Medical Oncology, Leiden University Medical Centre, Albinusdreef 2, po box 9600, 2300 RC Leiden, The Netherlands.; Department of Medical Oncology, Radboud University Medical Centre, Geert Grooteplein Zuid 10, 6500 HB Nijmegen, The Netherlands., Kapiteijn E; Department of Medical Oncology, Leiden University Medical Centre, Albinusdreef 2, po box 9600, 2300 RC Leiden, The Netherlands.
Publikováno v:
Cancers [Cancers (Basel)] 2019 Jul 18; Vol. 11 (7). Date of Electronic Publication: 2019 Jul 18.
Autor:
Schouwenburg MG; Department of Medical Oncology, Leiden University Medical Centre.; Dutch Institute for Clinical Auditing, Leiden., Jochems A; Department of Medical Oncology, Leiden University Medical Centre.; Dutch Institute for Clinical Auditing, Leiden., Leeneman B; Department of Health Technology Assessment, Erasmus School of Health Policy and Management., Franken MG; Institute for Medical Technology Assessment, Erasmus University., van den Eertwegh AJM; Department of Medical Oncology, VU University Medical Centre., Haanen JBAG; Departments of Medical Oncology., van Zeijl MCT; Department of Medical Oncology, Leiden University Medical Centre.; Dutch Institute for Clinical Auditing, Leiden., Aarts MJ; Department of Medical Oncology, Maastricht University Medical Centre, Maastricht., van Akkooi ACJ; Surgical Oncology, Netherlands Cancer Institute - Antoni van Leeuwenhoek Hospital, Amsterdam., van den Berkmortel FWPJ; Department of Internal Medicine, Zuyderland Medical Centre Geleen-Heerlen, Sittard-Geleen., Blokx WAM; Departments of Pathology., de Groot JWB; Department of Medical Oncology, Isala, Zwolle., Hospers GAP; Department of Medical Oncology, University Medical Centre Groningen, University of Groningen, Groningen., Kapiteijn E; Department of Medical Oncology, Leiden University Medical Centre., Koornstra RH; Medical Oncology, Radboud University Medical Centre, Nijmegen., Kruit WH; Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam., Louwman MWJ; Netherlands Comprehensive Cancer Organisation, Utrecht., Piersma D; Department of Internal Medicine, Medisch Spectrum Twente, Enschede., van Rijn RS; Department of Internal Medicine, Medical Centre Leeuwarden, Leeuwarden., Suijkerbuijk KPM; Department of Medical Oncology, University Medical Centre Utrecht Cancer Center, Utrecht., Ten Tije AJ; Departments of Medical Oncology.; Department of Internal Medicine, Amphia Hospital, Breda., Vreugdenhil G; Department of Internal Medicine, Maxima Medical Center, Veldhoven, The Netherlands., Wouters MWJM; Dutch Institute for Clinical Auditing, Leiden.; Surgical Oncology, Netherlands Cancer Institute - Antoni van Leeuwenhoek Hospital, Amsterdam., van der Hoeven JJM; Department of Medical Oncology, Leiden University Medical Centre.
Publikováno v:
Melanoma research [Melanoma Res] 2018 Aug; Vol. 28 (4), pp. 326-332.
Autor:
Jochems A; Department of Medical Oncology, Leiden University Medical Center.; Dutch Institute for Clinical Auditing, Leiden., Leeneman B; Department of Health Technology Assessment, Erasmus School of Health Policy & Management., Franken MG; Institute for Medical Technology Assessment, Erasmus University Rotterdam., Schouwenburg MG; Department of Medical Oncology, Leiden University Medical Center.; Dutch Institute for Clinical Auditing, Leiden., Aarts MJB; Department of Medical Oncology, Maastricht University Medical Center, Maastricht., van Akkooi ACJ; Departments of Surgical Oncology., van den Berkmortel FWPJ; Department of Internal Medicine, Zuyderland Medical Center Geleen, Heerlen., van den Eertwegh AJM; Dutch Institute for Clinical Auditing, Leiden.; Department of Medical Oncology, VU University Medical Center, Amsterdam., Groenewegen G; Department of Medical Oncology, University Medical Center Utrecht., de Groot JWB; Department of Medical Oncology, Isala, Zwolle., Haanen JBAG; Dutch Institute for Clinical Auditing, Leiden.; Medical Oncology, Netherlands Cancer Institute - Antoni van Leeuwenhoek Hospital., Hospers GAP; Department of Medical Oncology, University Medical Center Groningen, Groningen., Kapiteijn E; Department of Medical Oncology, Leiden University Medical Center., Koornstra RH; Department of Medical Oncology, Radboud University Medical Center, Nijmegen., Kruit WHJ; Department for Medical Oncology, Erasmus MC Cancer Institute, Rotterdam., Louwman MWJ; Netherlands Comprehensive Cancer Organisation, Utrecht., Piersma D; Department of Internal Medicine, Medical Spectrum Twente, Enschede., van Rijn RS; Department of Internal Medicine, Medical Center Leeuwarden, Leeuwarden., Ten Tije AJ; Department of Internal Medicine, Amphia Hospital, Breda., Vreugdenhil G; Department of Internal Medicine, Maxima Medical Center, Veldhoven, The Netherlands., Wouters MWJM; Dutch Institute for Clinical Auditing, Leiden.; Departments of Surgical Oncology., Uyl-de Groot CA; Department of Health Technology Assessment, Erasmus School of Health Policy & Management.; Institute for Medical Technology Assessment, Erasmus University Rotterdam., van der Hoeven KJM; Dutch Institute for Clinical Auditing, Leiden.; Department of Medical Oncology, Radboud University Medical Center, Nijmegen.
Publikováno v:
Anti-cancer drugs [Anticancer Drugs] 2018 Jul; Vol. 29 (6), pp. 572-578.
[Recent treatment results for metastatic melanoma: data from the Dutch Melanoma Treatment Registry].
Autor:
van Zeijl MCT; LUMC, afd. Heelkunde, Leiden.; Contact: M.C.T. van Zeijl (m.vanzeijl@dica.nl)., van den Eertwegh AJM; VUmc, afd. Medische oncologie, Amsterdam., Wouters MWJM; NKI-AVL, afd. Chirurgische Oncologie, Amsterdam., Jochems A; DICA, Leiden., Schouwenburg MG; DICA, Leiden., Haanen JBAG; NKI-AVL, afd. Medische oncologie en afd. Immunologie, Amsterdam., Aarts MJ; MUMC+, afd. Medische Oncologie, Maastricht., van den Berkmortel FWPJ; Zuyderland MC, afd. Medische oncologie, Heerlen., de Groot JWB; Isala, afd. Medische oncologie, Zwolle., Hospers GAP; UMCG, afd. Medische Oncologie, Groningen., Kapiteijn E; LUMC, afd. Medische Oncologie, Leiden., Koornstra RH; Radboudumc, afd. Medische Oncologie, Nijmegen., Piersma D; Medisch Spectrum Twente, afd. Medische oncologie, Enschede., van Rijn RS; Medisch Centrum Leeuwarden, afd. Medische oncologie, Leeuwarden., Suijkerbuijk KPM; UMC Utrecht, afd. Medische Oncologie, Utrecht., Ten Tije AJ; Amphia Ziekenhuis, afd. Medische oncologie, Breda., van der Veldt AAM; Erasmus MC, afd. Medische Oncologie, Rotterdam., Vreugdenhil G; Máxima Medisch Centrum, afd. Medische oncologie, Eindhoven., van der Hoeven KJM; Radboudumc, afd. Medische Oncologie, Nijmegen.
Publikováno v:
Nederlands tijdschrift voor geneeskunde [Ned Tijdschr Geneeskd] 2018 Jun 15; Vol. 162. Date of Electronic Publication: 2018 Jun 15.
Autor:
Jochems A; Department of Medical Oncology, Leiden University Medical Centre, Albinusdreef 2, 2333 ZA, Leiden, The Netherlands., Schouwenburg MG; Department of Medical Oncology, Leiden University Medical Centre, Albinusdreef 2, 2333 ZA, Leiden, The Netherlands., Leeneman B; Institute for Medical Technology Assessment, Erasmus University, Burgemeester Oudlaan 50, 3062 PA, Rotterdam, The Netherlands., Franken MG; Institute for Medical Technology Assessment, Erasmus University, Burgemeester Oudlaan 50, 3062 PA, Rotterdam, The Netherlands., van den Eertwegh AJ; Department of Medical Oncology, VU University Medical Centre, De Boelelaan 1118, 1081 HZ, Amsterdam, The Netherlands., Haanen JB; Department of Medical Oncology, Netherlands Cancer Institute - Antoni van Leeuwenhoek hospital, Plesmanlaan 121, 1066 CX, Amsterdam, The Netherlands., Gelderblom H; Department of Medical Oncology, Leiden University Medical Centre, Albinusdreef 2, 2333 ZA, Leiden, The Netherlands., Uyl-de Groot CA; Institute for Medical Technology Assessment, Erasmus University, Burgemeester Oudlaan 50, 3062 PA, Rotterdam, The Netherlands., Aarts MJ; Department of Medical Oncology, Maastricht University Medical Centre, P. Debyelaan 25, 6229 HX, Maastricht, The Netherlands., van den Berkmortel FW; Department of Internal Medicine, Zuyderland Medical Centre Heerlen-Sittard, Henri Dunantstraat 5, 6419 PC, Heerlen, The Netherlands., Blokx WA; Department of Pathology, Radboud University Medical Centre, Geert Grooteplein Zuid 10, 6525 GA, Nijmegen, The Netherlands., Cardous-Ubbink MC; Netherlands Comprehensive Cancer Organisation, Godebaldkwartier 419, 3511 DT, Utrecht, The Netherlands., Groenewegen G; Department of Medical Oncology, University Medical Centre Utrecht, Heidelberglaan 100, 3582, CX, Utrecht, The Netherlands., de Groot JW; Department of Medical Oncology, Isala, Dokter van Heesweg 2, 8025 AB, Zwolle, The Netherlands., Hospers GA; Department of Medical Oncology, University Medical Centre Groningen, Hanzeplein 1, 9713 GZ, Groningen, The Netherlands., Kapiteijn E; Department of Medical Oncology, Leiden University Medical Centre, Albinusdreef 2, 2333 ZA, Leiden, The Netherlands., Koornstra RH; Department of Medical Oncology, Radboud University Medical Centre, Geert Grooteplein Zuid 10, 6525 GA, Nijmegen, The Netherlands., Kruit WH; Department of Medical Oncology, Erasmus MC Cancer Institute, 's-Gravendijkwal 230, 3015 CE, Rotterdam, The Netherlands., Louwman MW; Netherlands Comprehensive Cancer Organisation, Godebaldkwartier 419, 3511 DT, Utrecht, The Netherlands., Piersma D; Department of Internal Medicine, Medisch Spectrum Twente, Koningsplein 1, 7512 KZ, Enschede, The Netherlands., van Rijn RS; Department of Internal Medicine, Medical Centre Leeuwarden, Henri Dunantweg 2, 8934 AD, Leeuwarden, The Netherlands., Ten Tije AJ; Department of Internal Medicine, Amphia Hospital, Molengracht 21, 4818 CK, Breda, The Netherlands., Vreugdenhil G; Department of Internal Medicine, Maxima Medical Centre, De Run 4600, 5504 DB, Eindhoven, The Netherlands., Wouters MW; Department of Surgical Oncology, Netherlands Cancer Institute - Antoni van Leeuwenhoek hospital, Plesmanlaan 121, 1066 CX, Amsterdam, The Netherlands., van der Hoeven JJ; Department of Medical Oncology, Leiden University Medical Centre, Albinusdreef 2, 2333 ZA, Leiden, The Netherlands. Electronic address: J.J.M.van_der_Hoeven@lumc.nl.
Publikováno v:
European journal of cancer (Oxford, England : 1990) [Eur J Cancer] 2017 Feb; Vol. 72, pp. 156-165. Date of Electronic Publication: 2016 Dec 25.
Autor:
Boudewijns S; Departments of *Medical Oncology †Tumor Immunology ‡Radiology and Nuclear Medicine, Radboud University Medical Center, Radboud Institute for Molecular Life Sciences, Nijmegen §Department of Medical Oncology, Academic Medical Center, Amsterdam, The Netherlands., Westdorp H, Koornstra RH, Aarntzen EH, Schreibelt G, Creemers JH, Punt CJ, Figdor CG, de Vries IJ, Gerritsen WR, Bol KF
Publikováno v:
Journal of immunotherapy (Hagerstown, Md. : 1997) [J Immunother] 2016 Jul-Aug; Vol. 39 (6), pp. 241-8.
Autor:
Boudewijns S; Department of Medical Oncology, Radboud University Medical Centre, Nijmegen, the Netherlands; Department of Tumor Immunology, Radboud Institute for Molecular Life Sciences, Radboud University Medical Center, Nijmegen, the Netherlands., Koornstra RH; Department of Medical Oncology, Radboud University Medical Centre , Nijmegen, the Netherlands., Westdorp H; Department of Medical Oncology, Radboud University Medical Centre, Nijmegen, the Netherlands; Department of Tumor Immunology, Radboud Institute for Molecular Life Sciences, Radboud University Medical Center, Nijmegen, the Netherlands., Schreibelt G; Department of Tumor Immunology, Radboud Institute for Molecular Life Sciences, Radboud University Medical Center , Nijmegen, the Netherlands., van den Eertwegh AJ; Department of Medical Oncology, Cancer Center Amsterdam, VU University Medical Center , Amsterdam, the Netherlands., Geukes Foppen MH; Department of Medical Oncology, Netherlands Cancer Institute , Amsterdam, the Netherlands., Haanen JB; Department of Medical Oncology, Netherlands Cancer Institute , Amsterdam, the Netherlands., de Vries IJ; Department of Medical Oncology, Radboud University Medical Centre, Nijmegen, the Netherlands; Department of Tumor Immunology, Radboud Institute for Molecular Life Sciences, Radboud University Medical Center, Nijmegen, the Netherlands., Figdor CG; Department of Tumor Immunology, Radboud Institute for Molecular Life Sciences, Radboud University Medical Center , Nijmegen, the Netherlands., Bol KF; Department of Medical Oncology, Radboud University Medical Centre, Nijmegen, the Netherlands; Department of Tumor Immunology, Radboud Institute for Molecular Life Sciences, Radboud University Medical Center, Nijmegen, the Netherlands., Gerritsen WR; Department of Medical Oncology, Radboud University Medical Centre , Nijmegen, the Netherlands.
Publikováno v:
Oncoimmunology [Oncoimmunology] 2016 Jun 17; Vol. 5 (8), pp. e1201625. Date of Electronic Publication: 2016 Jun 17 (Print Publication: 2016).
Autor:
Schreibelt G; Department of Tumor Immunology, Radboud Institute for Molecular Life Sciences, Radboud University Medical Center, Nijmegen, the Netherlands., Bol KF; Department of Tumor Immunology, Radboud Institute for Molecular Life Sciences, Radboud University Medical Center, Nijmegen, the Netherlands. Department of Medical Oncology, Radboud University Medical Center, Nijmegen, the Netherlands., Westdorp H; Department of Tumor Immunology, Radboud Institute for Molecular Life Sciences, Radboud University Medical Center, Nijmegen, the Netherlands. Department of Medical Oncology, Radboud University Medical Center, Nijmegen, the Netherlands., Wimmers F; Department of Tumor Immunology, Radboud Institute for Molecular Life Sciences, Radboud University Medical Center, Nijmegen, the Netherlands., Aarntzen EH; Department of Tumor Immunology, Radboud Institute for Molecular Life Sciences, Radboud University Medical Center, Nijmegen, the Netherlands. Department of Medical Oncology, Radboud University Medical Center, Nijmegen, the Netherlands. Radboud Institute for Molecular Life Sciences, Radboud University Medical Center, Nijmegen, the Netherlands., Duiveman-de Boer T; Department of Tumor Immunology, Radboud Institute for Molecular Life Sciences, Radboud University Medical Center, Nijmegen, the Netherlands., van de Rakt MW; Department of Tumor Immunology, Radboud Institute for Molecular Life Sciences, Radboud University Medical Center, Nijmegen, the Netherlands., Scharenborg NM; Department of Tumor Immunology, Radboud Institute for Molecular Life Sciences, Radboud University Medical Center, Nijmegen, the Netherlands., de Boer AJ; Department of Tumor Immunology, Radboud Institute for Molecular Life Sciences, Radboud University Medical Center, Nijmegen, the Netherlands., Pots JM; Department of Tumor Immunology, Radboud Institute for Molecular Life Sciences, Radboud University Medical Center, Nijmegen, the Netherlands., Olde Nordkamp MA; Department of Tumor Immunology, Radboud Institute for Molecular Life Sciences, Radboud University Medical Center, Nijmegen, the Netherlands., van Oorschot TG; Department of Tumor Immunology, Radboud Institute for Molecular Life Sciences, Radboud University Medical Center, Nijmegen, the Netherlands., Tel J; Department of Tumor Immunology, Radboud Institute for Molecular Life Sciences, Radboud University Medical Center, Nijmegen, the Netherlands., Winkels G; Miltenyi Biotec GmbH, Bergisch Gladbach, Germany., Petry K; Miltenyi Biotec GmbH, Bergisch Gladbach, Germany., Blokx WA; Department of Pathology, Radboud University Medical Center, Nijmegen, the Netherlands., van Rossum MM; Department of Dermatology, Radboud University Medical Center, Nijmegen, the Netherlands., Welzen ME; Department of Pharmacy, Radboud University Medical Center, Nijmegen, the Netherlands., Mus RD; Radboud Institute for Molecular Life Sciences, Radboud University Medical Center, Nijmegen, the Netherlands., Croockewit SA; Department of Hematology, Radboud University Medical Center, Nijmegen, the Netherlands., Koornstra RH; Department of Medical Oncology, Radboud University Medical Center, Nijmegen, the Netherlands., Jacobs JF; Department of Laboratory Medicine, Radboud University Medical Center, Nijmegen, the Netherlands., Kelderman S; Department of Immunology, Netherlands Cancer Institute NKI-AVL, Amsterdam, the Netherlands., Blank CU; Department of Immunology, Netherlands Cancer Institute NKI-AVL, Amsterdam, the Netherlands., Gerritsen WR; Department of Medical Oncology, Radboud University Medical Center, Nijmegen, the Netherlands., Punt CJ; Department of Medical Oncology, Academic Medical Center, Amsterdam, the Netherlands., Figdor CG; Department of Tumor Immunology, Radboud Institute for Molecular Life Sciences, Radboud University Medical Center, Nijmegen, the Netherlands., de Vries IJ; Department of Tumor Immunology, Radboud Institute for Molecular Life Sciences, Radboud University Medical Center, Nijmegen, the Netherlands. Department of Medical Oncology, Radboud University Medical Center, Nijmegen, the Netherlands. jolanda.devries@radboudumc.nl.
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2016 May 01; Vol. 22 (9), pp. 2155-66. Date of Electronic Publication: 2015 Dec 28.
Autor:
Koornstra RH; Department of Molecular Biology, Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX Amsterdam, The Netherlands; Department of Medical Oncology, Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX Amsterdam, The Netherlands. Electronic address: r.koornstra@nki.nl., Beelen KJ; Department of Molecular Biology, Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX Amsterdam, The Netherlands; Department of Medical Oncology, Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX Amsterdam, The Netherlands., Vincent AD; Department of Biometrics, The Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX Amsterdam, The Netherlands., van der Noort V; Department of Biometrics, The Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX Amsterdam, The Netherlands., van Diest PJ; Department of Pathology, University Medical Center Utrecht, Heidelberglaan 100, 3584 CX Utrecht, The Netherlands., Linn SC; Department of Molecular Biology, Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX Amsterdam, The Netherlands; Department of Medical Oncology, Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX Amsterdam, The Netherlands; Department of Pathology, University Medical Center Utrecht, Heidelberglaan 100, 3584 CX Utrecht, The Netherlands.
Publikováno v:
Breast (Edinburgh, Scotland) [Breast] 2015 Dec; Vol. 24 (6), pp. 705-12. Date of Electronic Publication: 2015 Oct 01.